Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ACTRT1 pseudogene 1 (ACTRT1P1) is a processed, nonprotein-coding segment of DNA that closely resembles the ACTRT1 gene, but it is rendered nonfunctional due to inactivating mutations acquired over evolutionary time[5][7][9][11]. Unlike its parental gene ACTRT1—which codes for actin-related protein T1 involved in spermatozoon structure and has documented roles in certain genetic disorders and cancers—ACTRT1P1 as a pseudogene does not produce a functional protein and is not considered a therapeutic target. While some pseudogenes in general may modulate gene expression by acting as competing endogenous RNAs or via other RNA-based regulatory mechanisms, there is currently no evidence indicating a biological or disease-related function for ACTRT1P1[4][8]. Important context: The functional gene, ACTRT1 (actin-related protein T1), is involved in male fertility and may act as a tumor suppressor[1][2][3][12]. However, ACTRT1P1 is a distinct, nonfunctional pseudogene located downstream of ACTRT1 and is not implicated in these disease contexts or considered druggable[5]. Pseudogenes are increasingly recognized for potential regulatory functions in some cases, but these are exceptional and not established for ACTRT1P1[4][8]. Therefore, ACTRT1P1 should not be used as a canonical form for drug target information, and returning data from ACTRT1 or ARPT1 in its place would be inaccurate for biomedical databases focused on druggable targets.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ACTRT1 pseudogene 1 (ACTRT1P1).